City noise worsens fibromyalgia pain, new research reveals—urban sounds trigger sharper symptoms than silence or...
Discover how spinal muscular atrophy treatment has evolved with disease-modifying therapies and early intervention for...
Spinal muscular atrophy care has evolved with disease-modifying drugs, enabling patients to live longer and...
FDA approves tau PET imaging agent Tauklarify for Alzheimer’s disease, backed by two large studies...
Blood biomarkers are revolutionizing early Alzheimer detection, with a new P‑tau217 blood test matching PET...
Spinal muscular atrophy treatment breakthroughs extend lives, but healthcare systems struggle to adapt to new...
Discover the latest developments in Spinal Muscular Atrophy treatment during SMA Awareness Month, highlighting new...
Thymidine kinase deficiency approval brings new hope as drugs doxecitine and doxribtimine receive regulatory clearance,...
The FDA will review tau PET imaging agent MK-6240 on August 13, seeking better Alzheimer...
New data regarding CIDP treatment with efgartigimod PH20 reveals long-term patient outcomes for clinicians based...